Webinar Registration
Clinical TRials
Exciting news! Aardvark Therapeutics will soon be opening sites in the UK to trial ARD-101. ARD-101 is a novel, orally administered investigational therapy being studied for its potential to reduce excessive hunger and food-seeking behaviours in individuals with PWS. The sites are due to open in the new year and will be located in London, Glasgow, Cambridge, and Leicester.
PWS Stronger Together are hosting a webinar with all the information you need about the ARD-101 trial.
Join us at 7:00 pm on Tuesday, 20 January 2026.
Register for the webinar using the form below.
Your registration could not be saved. Please try again.
Your registration has been successful. You will receive a link for the webinar the week before the planned date.

